What did @dressagehub_official actually say?
The creator claims BPC-157, TB-500, and KPV are "approved for veterinary use" and that BPC-157 acted like a "magic potion" for her injured dog, nearly restoring full gait after years of lameness. She also implies the same logic applies to horses and humans in the equestrian world.
To be specific: she says her dog tore her iliopsoas muscle, was managed but never fully sound, and that after starting BPC-157 (alongside TB-500 and KPV), the dog is "running around more," "happier," and her "gait is almost 100%." She notes her vet is aware and supportive. She frames this as a straightforward win and calls the compound essentially magic.
That personal story is compelling. But several of the regulatory and scientific claims wrapped around it need serious scrutiny.
Does the science back this up?
The preclinical data on BPC-157 is genuinely interesting, but it is almost entirely animal-based, and none of it has been validated in randomized controlled trials in humans or companion animals. Calling it proven is a stretch the evidence does not support.
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. Rodent studies, particularly from Sikiric et al. across multiple publications in journals like Current Pharmaceutical Design (2018), show accelerated tendon-to-bone healing, angiogenesis promotion, and anti-inflammatory effects. TB-500 (a thymosin beta-4 fragment) has similar preclinical support for tissue repair. These are real signals worth studying. But rodent models do not reliably translate to clinical outcomes in humans or even dogs. The leap from "works in rats" to "magic potion" is not a scientific one. KPV, a tripeptide with anti-inflammatory properties, has even thinner published literature. No peer-reviewed trial has confirmed efficacy or safety for any of these compounds in canine musculoskeletal injury.
What did they get wrong (or right)?
The "approved for veterinary use" claim is the most significant problem here. It is misleading in a way that could genuinely affect how viewers make decisions for their animals.
BPC-157 does not hold FDA approval for veterinary use. It is not on the USDA or FDA's approved veterinary drug lists. Compounding pharmacies in the U.S. can legally prepare BPC-157 for use in animals under a veterinarian's direction, which is a different regulatory category entirely. "Compounded" and "approved" are not the same thing, and conflating them is the kind of error that has real consequences. A pet owner hearing "approved for veterinary use" may assume a level of safety review that simply has not happened. To her credit, the creator does say her vet knows and is supportive, which is the responsible framing. The anecdote about her dog's improvement is also entirely plausible given the preclinical literature, even if it is not proof of anything. And she is right that equestrian athletes and their animals sustain a disproportionate share of musculoskeletal injuries. The interest in faster recovery tools is legitimate even if the evidence base is not yet there.
What should you actually know?
If you are considering peptides for yourself or your animal, the regulatory and evidence picture is more complicated than this video suggests, and getting it wrong has consequences.
BPC-157 has never completed a phase 2 or phase 3 clinical trial in humans. A phase 2 trial for inflammatory bowel disease was initiated but results have not been published in a peer-reviewed format. The FDA has flagged BPC-157 as not an approved drug for human use and has taken action against some compounders marketing it for human administration. For animals, compounded BPC-157 can be legally prescribed by a licensed veterinarian, but that is a legal carve-out for compounding, not a regulatory approval. If your vet recommends it for your dog or horse, that is a clinical decision they are making under their license with limited evidence behind it. The "magic potion" framing also glosses over the fact that we do not have solid safety data for long-term use in any species. Anecdotal improvement in a single dog is a case report, not a clinical signal. It is worth taking seriously, but not worth generalizing from.